Aurdan Capital Management, LLC Abbott Laboratories Transaction History
Aurdan Capital Management, LLC
- $265 Billion
- Q1 2025
A detailed history of Aurdan Capital Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Aurdan Capital Management, LLC holds 37,989 shares of ABT stock, worth $5.25 Million. This represents 1.9% of its overall portfolio holdings.
Number of Shares
37,989
Previous 47,884
20.66%
Holding current value
$5.25 Million
Previous $5.42 Billion
6.96%
% of portfolio
1.9%
Previous 2.08%
Shares
2 transactions
Others Institutions Holding ABT
# of Institutions
3,545Shares Held
1.38BCall Options Held
9.75MPut Options Held
8.87M-
Vanguard Group Inc Valley Forge, PA170MShares$23.4 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY131MShares$18.1 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.7MShares$10.7 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA66.8MShares$9.23 Billion1.82% of portfolio
-
Capital Research Global Investors Los Angeles, CA50.7MShares$7.01 Billion1.53% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $242B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...